Skip to main content
. 2023 May 24;21:190. doi: 10.1186/s12916-023-02900-z

Table 4.

Change in hematology parameters relative to normal range from screening to week 24 — safety analysis set

Parameter, n (%) Placebo (n = 10) IMCY-0098 dose A (n = 6) IMCY-0098 dose B (n = 9) IMCY-0098 dose C (n = 16) Total (N = 41)
Erythrocytes (10^12/L) n [1] 10 6 9 16 41
Decrease to low 0 0 4 (44.4) 3 (18.8) 7 (17.1)
Change to normal or no change 10 (100) 6 (100) 5 (55.6) 13 (81.3) 34 (82.9)
Increase to high 0 0 0 0 0
Monocytes (10^9/L) n [1] 10 6 9 16 41
Decrease to low 0 0 2 (22.2) 0 2 (4.9)
Change to normal or no change 9 (90.0) 6 (100) 6 (66.7) 14 (87.5) 35 (85.4)
Increase to high 1 (10.0) 0 1 (11.1) 2 (12.5) 4 (9.8)
Lymphocytes/leukocytes (%) n [1] 10 6 9 16 41
Decrease to low 2 (20.0) 0 1 (11.1) 2 (12.5) 5 (12.2)
Change to normal or no change 6 (60.0) 4 (66.7) 7 (77.8) 12 (75.0) 29 (70.7)
Increase to high 2 (20.0) 2 (33.3) 1 (11.1) 2 (12.5) 7 (17.1)
Monocytes/leukocytes (%) n [1] 10 6 9 16 41
Decrease to low 1 (10.0) 1 (16.7) 0 0 2 (4.9)
Change to normal or no change 8 (80.0) 3 (50.0) 9 (100) 15 (93.8) 35 (85.4)
Increase to high 1 (10.0) 2 (33.3) 0 1 (6.3) 4 (9.8)
Granulocytes/leukocytes (%) n [1] 0 0 0 1 1
Decrease to low 0 0 0 0 0
Change to normal or no change 0 0 0 1 (100) 1 (100)
Increase to high 0 0 0 0 0
Neutrophile granulocytes (10^9/L) n [1] 10 6 9 16 41
Decrease to low 1 (10.0) 1 (16.7) 1 (11.1) 1 (6.3) 4 (9.8)
Change to normal or no change 7 (70.0) 5 (83.3) 7 (77.8) 12 (75.0) 31 (75.6)
Increase to high 2 (20.0) 0 1 (11.1) 3 (18.8) 6 (14.6)
Eosinophile granulocytes (10^9/L) n [1] 10 6 9 16 41
Decrease to low 1 (10.0) 0 0 1 (6.3) 2 (4.9)
Change to normal or no change 8 (80.0) 6 (100) 8 (88.9) 14 (87.5) 36 (87.8)
Increase to high 1 (10.0) 0 1 (11.1) 1 (6.3) 3 (7.3)
Bas. granulocytes (10^9/L) n [1] 10 6 9 16 41
Decrease to low 0 0 0 0 0
Change to normal or no change 9 (90.0) 4 (66.7) 8 (88.9) 14 (87.5) 35 (85.4)
Increase to high 1 (10.0) 2 (33.3) 1 (11.1) 2 (12.5) 6 (14.6)
Neutrophile granulocytes/leukocytes (%) n [1] 10 6 9 16 41
Decrease to low 0 0 1 (11.1) 1 (6.3) 2 (4.9)
Change to normal or no change 9 (90.0) 6 (100) 8 (88.9) 13 (81.3) 36 (87.8)
Increase to high 1 (10.0) 0 0 2 (12.5) 3 (7.3)
Neutr. granulocytes/leukocytes (%) n [1] 0 2 0 1 3
Decrease to low 0 1 (50.0) 0 0 1 (33.3)
Change to normal or no change 0 1 (50.0) 0 1 (100) 2 (66.7)
Increase to high 0 0 0 0 0
Eosinophile granulocytes/leukocytes (%) n [1] 10 6 9 16 41
Decrease to low 1 (10.0) 0 0 1 (6.3) 2 (4.9)
Change to normal or no change 7 (70.0) 5 (83.3) 9 (100) 14 (87.5) 35 (85.4)
Increase to high 2 (20.0) 1 (16.7) 0 1 (6.3) 4 (9.8)
Eosin. granulocytes/leukocytes (%) n [1] 0 2 0 1 3
Decrease to low 0 0 0 0 0
Change to normal or no change 0 2 (100) 0 1 (100) 3 (100)
Increase to high 0 0 0 0 0
Basophile granulocytes/leukocytes (%) n [1] 0 2 0 0 2
Decrease to low 0 0 0 0 0
Change to normal or no change 0 0 0 0 0
Increase to high 0 2 (100) 0 0 2 (100)
Bas. granulocytes/leukocytes (%) n [1] 10 6 9 16 41
Decrease to low 0 0 0 0 0
Change to normal or no change 10 (100) 5 (83.3) 8 (88.9) 16 (100) 39 (95.1)
Increase to high 0 1 (16.7) 1 (11.1) 0 2 (4.9)
Lymphocytes atypical/leukocytes (%) n [1] 0 2 0 1 3
Decrease to low 0 0 0 0 0
Change to normal or no change 0 0 0 0 0
Increase to high 0 2 (100) 0 1 (100) 3 (100)
Smudge cells/leukocytes (%) n [1] 0 2 0 0 2
Decrease to low 0 0 0 0 0
Change to normal or no change 0 2 (100) 0 0 2 (100)
Increase to high 0 0 0 0 0

n [1], subjects with at least one report